Wim J. Sluiter

12.9k citations

252 papers · 9.8k indexed · 1 hit paper · h-index 55

Surgery top 0.5%
Molecular Biology top 5%
Endocrinology, Diabetes and Metabolism top 0.5%
Epidemiology top 1%
Oncology top 2%

Co-authors: Elisabeth G.E. de Vries Robin P. F. Dullaart Arie van Tol Thera P. Links Robin P.F. Dullaart Anneke Pietersma Pieter L. Jager Johan F. Koster
Topics: Pituitary Gland Disorders and Treatments (23 papers)Thyroid Cancer Diagnosis and Treatment (18 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers)
Cited by: Endocrinology, Diabetes and Metabolism Obstetrics and Gynecology Surgery
Journals: The Lancet Circulation Journal of Clinical Investigation
Partner nations: Netherlands United States Germany

In The Last Decade

Wim J. Sluiter

252 papers receiving 9.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sentinel Node Dissection Is Safe in the Treatment of Early-Stage Vulvar Cancer

2008 509 citations Ate G.J. van der Zee, Wim J. Sluiter et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Wim J. Sluiter

Since Specialization

Citations

This map shows the geographic impact of Wim J. Sluiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wim J. Sluiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wim J. Sluiter more than expected).

Fields of papers citing papers by Wim J. Sluiter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wim J. Sluiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wim J. Sluiter. The network helps show where Wim J. Sluiter may publish in the future.

Co-authorship network of co-authors of Wim J. Sluiter

This figure shows the co-authorship network connecting the top 25 collaborators of Wim J. Sluiter. A scholar is included among the top collaborators of Wim J. Sluiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wim J. Sluiter. Wim J. Sluiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Primary aldosteronism is associated with decreased low‐density and high‐density lipoprotein particle concentrations and increased GlycA, a pro‐inflammatory glycoprotein biomarker 2018 ·Clinical Endocrinology ·Annika M.A. Berends,Edward Buitenwerf,Eke G. Gruppen,Wim J. Sluiter,Stephan J. L. Bakker,Margery A. Connelly,Michiel N. Kerstens,Robin P. F. Dullaart	17
2	Higher plasma GlycA, a novel pro-inflammatory glycoprotein biomarker, is associated with reduced life expectancy: The PREVEND study 2018 ·Clinica Chimica Acta ·Eke G. Gruppen,Margery A. Connelly,Wim J. Sluiter,Stephan J. L. Bakker,Robin P. F. Dullaart	18
3	Recombinant TSH Stimulated Remnant Ablation Therapy in Thyroid Cancer: The Success Rate Depends on the Definition of Ablation Success—An Observational Study 2015 ·PLoS ONE ·Anouk N.A. van der Horst‐Schrivers,Wim J. Sluiter,Anneke C. Muller Kobold,Bruce H. R. Wolffenbuttel,John Th. M. Plukker,Peter H. Bisschop,(unknown),Imad Al Younis,Paul Lips,Johannes W. A. Smit,Adrienne H. Brouwers,Thera P. Links	2
4	Hydrocortisone Dose Influences Pain, Depressive Symptoms and Perceived Health in Adrenal Insufficiency: A Randomized Controlled Trial 2015 ·Neuroendocrinology ·(unknown),(unknown),Janneke Koerts,Robin P. F. Dullaart,Gerrit van den Berg,Melanie M. van der Klauw,Wim J. Sluiter,Oliver Tucha,Bruce H. R. Wolffenbuttel,André P. van Beek	24
5	The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone 2012 ·Radiotherapy and Oncology ·M. Sattler,André P. van Beek,Bruce H. R. Wolffenbuttel,Gerrit van den Berg,Wim J. Sluiter,Johannes A. Langendijk,A.C.M. van den Bergh	37
6	Defective NDUFA9 as a novel cause of neonatally fatal complex I disease 2011 ·Journal of Medical Genetics ·B.J.C. van den Bosch,Mike Gerards,Wim J. Sluiter,Alexander P.A. Stegmann,(unknown),Debby M.E.I. Hellebrekers,Renske Oegema,(unknown),Holger Prokisch,Katharina Danhauser,Kees Schoonderwoerd,I.F.M. de Coo,Hubert J.M. Smeets	46
7	Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly 2011 ·(unknown),Romana T. Netea‐Maier,(unknown),J. Homan,Wim J. Sluiter,(unknown),Bruce H. R. Wolffenbuttel,A. R. M. M. Hermus,(unknown)	1
8	Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity 2010 ·Journal of Translational Medicine ·Ruud CW Vermeulen,(unknown),Frans C. Visser,Wim J. Sluiter,H.R. Scholte	115
9	Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus 2010 ·Atherosclerosis ·Paul J.W.H. Kappelle,Josefin Ahnström,Bert D. Dikkeschei,Rindert de Vries,Wim J. Sluiter,Bruce H. R. Wolffenbuttel,Arie van Tol,Lars B. Nielsen,Björn Dahlbäck,Robin P. F. Dullaart	11
10	MEF2 Transcriptional Activity Maintains Mitochondrial Adaptation in Cardiac Pressure Overload 2009 ·European Journal of Heart Failure ·Hamid el Azzouzi,Ralph J. van Oort,Roel van der Nagel,Wim J. Sluiter,Martin Bergmann,León J. De Windt	22
11	Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus 2009 ·Diabetologia ·Helen L. Lutgers,Esther G. Gerrits,(unknown),Thera P. Links,Wim J. Sluiter,Rijk O. B. Gans,H. J. G. Bilo,Andries J. Smit	139
12	Improved Staging of Patients With Carcinoid and Islet Cell Tumors With ¹⁸F-Dihydroxy-Phenyl-Alanine and ¹¹C-5-Hydroxy-Tryptophan Positron Emission Tomography 2008 ·Journal of Clinical Oncology ·Klaas Pieter Koopmans,Oliver Neels,Ido P. Kema,Philip H. Elsinga,Wim J. Sluiter,(unknown),Adrienne H. Brouwers,Pieter L. Jager,Elisabeth G.E. de Vries	163
13	Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol 2008 ·European Journal of Endocrinology ·Robin P. F. Dullaart,Albert K. Groen,Geesje M. Dallinga‐Thie,Rindert de Vries,Wim J. Sluiter,Arie van Tol	29
14	P53‐specific T cell responses in patients with malignant and benign ovarian tumors: Implications for p53 based immunotherapy 2007 ·International Journal of Cancer ·Annechien J.A. Lambeck,Ninke Leffers,Baukje‐Nynke Hoogeboom,Wim J. Sluiter,(unknown),Harry Klip,(unknown),(unknown),(unknown),Jan W. Drijfhout,Inge Platteel,Rienk Offringa,Harry Hollema,(unknown),Sjoerd van der Burg,Ate G.J. van der Zee,Toos Daemen,Hans W. Nijman	31
15	The Influence of Reactive Oxygen Species on the Adhesion of Pancreatic Carcinoma Cells to the Peritoneum 2007 ·Cell Adhesion & Migration ·Sander Ten Raa,(unknown),(unknown),(unknown),Leo J. Hofland,Hans Jeekel,Wim J. Sluiter,Casper H.J. van Eijck	10
16	Vascular events after liver transplantation: a long-term follow-up study 2007 ·Transplant International ·(unknown),(unknown),Wim J. Sluiter,Maarten J. H. Slooff,Elizabeth B. Haagsma,A. P. van den Berg	35
17	Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma 2006 ·Blood ·(unknown),Josée M. Zijlstra,Wim J. Sluiter,Gustaaf W. van Imhoff,Jan Pruim,Willem Vaalburg,Edo Vellenga	96
18	EUK-8, a Superoxide Dismutase and Catalase Mimetic, Reduces Cardiac Oxidative Stress and Ameliorates Pressure Overload-Induced Heart Failure in the Harlequin Mouse Mutant 2006 ·Journal of the American College of Cardiology ·Vanessa van Empel,A. Bertrand,Ralph J. van Oort,Roel van der Nagel,Markus A. Engelen,Harold V.M. van Rijen,Pieter A. Doevendans,Harry J.G.M. Crijns,Susan L. Ackerman,Wim J. Sluiter,León J. De Windt	103
19	Combined thalidomide and cyclophosphamide treatment for refractory or relapsed multiple myeloma patients: a prospective phase II study 2004 ·Annals of Hematology ·Sjoerd Hovenga,Simon Daenen,J. Th. M. de Wolf,Gustaaf W. van Imhoff,Hanneke C. Kluin‐Nelemans,Wim J. Sluiter,Edo Vellenga	28
20	Dietary supplementation with fish oil modifies renal reserve filtration capacity in postoperative, cyclosporin A-treated renal transplant recipients 1990 ·Transplant International ·(unknown),H. J. G. Bilo,A. J. M. Donker,J. M. Wilmink,Wim J. Sluiter,Adam Tegzess	15

About Wim J. Sluiter

Wim J. Sluiter is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Surgery, having authored 252 papers that have together received 9.8k indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (23 papers), Thyroid Cancer Diagnosis and Treatment (18 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.0k citations), Obstetrics and Gynecology (690 citations) and Surgery (2.8k citations). Wim J. Sluiter has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Elisabeth G.E. de Vries, Robin P. F. Dullaart, Arie van Tol, Thera P. Links, Robin P.F. Dullaart, Anneke Pietersma, Pieter L. Jager, Johan F. Koster, Bruce H. R. Wolffenbuttel and J.F. Koster. Their work appears in journals such as The Lancet, Circulation and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact